Non-redundant activity of GSK-3α and GSK-3β in T cell-mediated tumor rejection.

Autor: Steele L; Leeds Institute of Medical Research, University of Leeds, School of Medicine, Wellcome Trust Brenner Building, St James's University Hospital, Leeds LS9 7TF, UK., Mannion AJ; Leeds Institute of Medical Research, University of Leeds, School of Medicine, Wellcome Trust Brenner Building, St James's University Hospital, Leeds LS9 7TF, UK.; Department of Oncology-Pathology, Karolinska Institute, Stockholm, Sweden., Shaw G; Leeds Institute of Medical Research, University of Leeds, School of Medicine, Wellcome Trust Brenner Building, St James's University Hospital, Leeds LS9 7TF, UK., Maclennan KA; Leeds Institute of Medical Research, University of Leeds, School of Medicine, Wellcome Trust Brenner Building, St James's University Hospital, Leeds LS9 7TF, UK., Cook GP; Leeds Institute of Medical Research, University of Leeds, School of Medicine, Wellcome Trust Brenner Building, St James's University Hospital, Leeds LS9 7TF, UK., Rudd CE; Division of Immunology-Oncology Research Center, Maisonneuve-Rosemont Hospital, Montreal, Quebec H1T 2M4, Canada.; Département de Medicine, Université de Montréal, Montreal, Quebec H3C 3J7, Canada.; Division of Experimental Medicine, Department of Medicine, McGill University Health Center, McGill University, Montreal, Quebec H4A 3J1, Canada., Taylor A; Leeds Institute of Medical Research, University of Leeds, School of Medicine, Wellcome Trust Brenner Building, St James's University Hospital, Leeds LS9 7TF, UK.

Publikováno v: IScience [iScience] 2021 May 19; Vol. 24 (6), pp. 102555. Date of Electronic Publication: 2021 May 19 (Print Publication: 2021).

The International Prognostic Index predicts outcome in aggressive adult T-cell leukemia/lymphoma: analysis of 126 patients from the International Peripheral T-Cell Lymphoma Project

Autor: Suzumiya J, Ohshima K, Tamura K, Karube K, Uike N, Tobinai K, Gascoyne RD, Vose JM, Armitage JO, Weisenburger DD, for the International Peripheral T. Cell Lymphoma Project [Savage K, Connors J, Gascoyne R, Chhanabhai M, Wilson W, Jaffe E, Armitage J, Vose J, Weisenburger D, Anderson J, Ullrich F, Bast M, Hochberg E, Harris N, Levine A, Nathwani B, Miller T, Rimsza L, Montserrat E, Lopez Guillermo A, Campo E, Cuadros M, Alvarez Ferreira J, Martinez Delgado B, Holte H, Delabie J, Rüdiger T, Müller Hermelink K, Reimer P, Adam P, Wilhelm M, Schmitz N, Nerl C, MacLennan KA, Federico M, Bellei M, Coiffier B, Berger F, Tanin I, Wannakrairot P, Au W, Liang R, Loong F, Rajan S, Sng I, Matsuno Y, Morishima Y, Nakamura S, Seto M, Tanimoto M, Yoshino T, Kim WS, Ko Y.H. ], ZINZANI, PIER LUIGI, PILERI, STEFANO

Background: The International Peripheral T-cell Lymphoma Project was organized to better understand the T-cell and natural killer (NK) cell lymphomas, and our task is to present the clinicopathologic correlations and therapeutic results for adult T-c

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::44cefa6a20199fa7260dc1f3a34e0df7
http://hdl.handle.net/11585/119626

Cytokine-induced killer cells: new insights for therapy of hematologic malignancies.

Autor: Ghanbari Sevari, Faezeh¹ (AUTHOR), Mehdizadeh, Amir¹ (AUTHOR), Abbasi, Khadijeh² (AUTHOR), Hejazian, Seyyed Sina^3,4 (AUTHOR) hejazians@tbzmed.ac.ir, Raisii, Mortaza¹ (AUTHOR) raisim@tbzmed.ac.ir

Publikováno v: Stem Cell Research & Therapy. 8/13/2024, Vol. 15 Issue 1, p1-21. 21p.

Novel clinical risk stratification and treatment strategies in relapsed/refractory peripheral T-cell lymphoma.

Autor: Chang, Esther Wei Yin^1,2 (AUTHOR) esther.chang.w.y@singhealth.com.sg, Tan, Ya Hwee^1,2 (AUTHOR), Chan, Jason Yongsheng^1,2,3 (AUTHOR) jason.chan.y.s@singhealth.com.sg

Publikováno v: Journal of Hematology & Oncology. 6/1/2024, Vol. 17, p1-20. 20p.

Workshop report on Hodgkin's disease and related diseases ('grey zone' lymphoma)

Autor: Rudiger, T, Jaffe, ES, Delsol, G, deWolf-Peeters, C, Gascoyne, RD, Georgii, A, Harris, NL, Kadin, ME, MacLennan, KA, Poppema, S, Stein, H, Weiss, LE, Muller-Hermelink, HK

Publikováno v: Annals of Oncology, 9, 31-38. Oxford University Press

Despite advances in immunohistochemistry and molecular biology, the distinction between classical Hodgkin's lymphoma and related diseases such as nodular lymphocyte-predominant Hodgkin's disease, T-cell rich large B-cell lymphoma or anaplastic large

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=narcis______::2d0b2fff05a4e61b3a04466fdfc4d21f
https://research.rug.nl/en/publications/7742cbca-51e5-42ab-a3e9-a4b9f6d35935